The Unmeasured Burden of Glaucoma: Part 2 - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Unmeasured Burden of Glaucoma: Part 2

How does one continue to live well when living with glaucoma-related vision impairment?

  • By

  • Kesh Patel

  • September 16, 2026

  • 7 min

Share

Clinical Report: The Unmeasured Burden of Glaucoma: Part 2

Background

Glaucoma is commonly assessed through measurable clinical metrics, yet many patients experience significant emotional and practical challenges that are not captured by these metrics.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

  • Adaptation to vision impairment is an ongoing process that evolves over time.
  • Everyday challenges related to vision impairment can significantly impact confidence and independence.
  • Small environmental adjustments can facilitate continued engagement in daily activities.
  • Conversations about managing life with glaucoma can uncover hidden challenges and promote practical strategies.
  • Patients often remain active and engaged in their lives despite vision changes, challenging the misconception of inevitable dependence.

Clinical Implications

Eye care professionals should incorporate discussions about adaptation strategies into patient care.

Conclusion

Recognizing the unmeasured burdens of glaucoma is essential.

Related Resources & Content

  1. The ophthalmologist, The Unmeasured Burden of Glaucoma, 2026 -- The Unmeasured Burden of Glaucoma
  2. Frontiers in Ophthalmology — Diagnostic Burdens in High Myopia
  3. Eye — Automated Large-Scale Assessment of Glaucoma Severity and Progression Based on Perimetry Data
  4. Ophthalmology Management — Glaucoma progression detection, part 2
  5. Primary Open-Angle Glaucoma Preferred Practice Pattern® - Ophthalmology
  6. Advancing glaucoma care: What's new in the 6th edition of the European Glaucoma Society guidelines
  7. Overview | Glaucoma: diagnosis and management | Guidance | NICE
  8. Evaluating Primary Treatment for People with Advanced Glaucoma
  9. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension - PubMed
  10. Depression and Depressive Symptoms in Glaucoma: A Systematic Review and Meta‐Analysis of Comparative, Prevalence, and Longitudinal Evidence - PMC
  11. Location of visual field defects and their impact on vision‐related quality of life in glaucoma: A systematic review - Higgins - 2026 - Optometry and Vision Science - Wiley Online Library
  12. Global, regional, and national burden of glaucoma, 1990-2023: a systematic analysis of the Global Burden of Disease Study 2023 - PubMed

Original Source(s)

The Unmeasured Burden of Glaucoma: Part 2

  • by Kesh Patel

  • September 16, 2026

Related Content

EGS Leaders Chart the Future of Glaucoma Care

Incoming and outgoing EGS presidents discuss the technologies, challenges, and priorities shaping the future of glaucoma care

Perspectives on Medicare’s Proposed iDose TR Coverage Policy

In May 2026, 5 Medicare Administrative Contractors released proposed Local Coverage Determinations (LCDs) addressing Medicare reimbursement for anterior-segment intraocular nonbiodegradable drug-eluting systems, a category that currently includes only the travoprost intracameral implant iDose TR (Glaukos). Many glaucoma specialists believe the proposed LCDs do not reflect contemporary glaucoma practice or the clinical rationale underlying sustained drug-delivery therapies. Glaucoma Physician spoke with several leading surgeons about the proposed LCDs, the reasons for their concerns, and the changes they believe would better reflect contemporary glaucoma practice.

Look Beyond the Bottle in Glaucoma Care

Embracing interventional glaucoma will enhance future treatment and outcomes.